170
Participants
Start Date
September 14, 2020
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2025
Immunofluorescence Imaging
Patients will be administered FDA approved ICG through intravenous injection and imaged by a FDA approved surgical microscope (Spy Elite) which is 0.5 meter away from the subject. Both ICG fluorescence and the two imaging systems have been used for routine clinical practice for many years. Figure (a) shows the Schematic sketch of the imaging systems. ICG fluorescence imaging utilizes intravenously injected ICG, which is a fluorescent dye that is FDA-approved for clinical use, illuminated with near-infrared light. The ICG dye is indirectly activated and the dynamic fluorescence due to bone perfusion can be captured by a video rate imaging system.
DCE-MRI
Characterize the relationship between bone perfusion as quantified by ICG based DCE-FI and DCE-MRI in human patients to develop an accurate depth-sensitive fluorescence imaging model that will correct for the surface-weighted feature of fluorescence imaging
University of Maryland, Baltimore R. Adams Cowley Shock Trauma, Baltimore
University of California, Irvine, Irvine
Brigham and Women's Hospital, Boston
Dartmouth Hitchcock Medical Center, Lebanon
Dartmouth College
OTHER
University of Maryland, Baltimore
OTHER
University of California, Irvine
OTHER
Dartmouth-Hitchcock Medical Center
OTHER